К вопросу о роли биологических и психологических факторов в развитии постинсультной депрессии
Рекомендуемое оформление библиографической ссылки:
Кутлубаев М.А., Менделевич В.Д., Ахмадеева Л.Р. К вопросу о роли биологических и психологических факторов в развитии постинсультной депрессии // Российский психиатрический журнал. 2018. №1. С. 71-77.
Депрессия – одно из самых частых нейропсихиатрических расстройств после инсульта. Она ухудшает качество жизни пациентов и прогноз инсульта. По мнению ряда авторов, развитие постинсультной депрессии связано с поражением левого полушария, особенно его передних отделов. Однако эти данные подтвердились не во всех исследованиях. Другие теории объясняют развитие постинсультной депрессии хроническим поражением головного мозга (лейкоареоз, атрофия), нейроиммунными и нейроэндокринными нарушениями, а также генетической предрасположенностью. Важная роль в развитии постинсультной депрессии отводится психологическим механизмам. Постинсультную депрессию условно можно подразделить на преимущественную эндоформную (органическую) и реактивную формы. Соотношение роли биологических и психологических факторов в развитии постинсультной депрессии индивидуально в каждом случае. Будущие исследования должны уточнить роль биологических и психологических факторов в развитии постинсультной депрессии с помощью современных методов исследования.
Ключевые слова депрессия; инсульт; лейкоареоз; атрофия; воспаление
1. Skvortcova VI, Kontcevoi VA, Petrova EA, Savina MA. [Depression and paradepressive disorders in cerebral stroke]. Zh Nevrol Psikhiatr Im S S Korsakova. 2009;109:4–11. Russian. PMID: 19817007 2. Kutlubaev MA, Hackett ML. Part II: predictors of depression after stroke and impact of depression on stroke outcome: an updated systematic review of observational studies. International Journal of Stroke. 2014;9:1026–36. 3. Dobrokhotova TA. Neuropsychiatry. Moscow, Meditcina. 2006. 232 p. Russian. 4. Robinson RG, Shoemaker WJ, Schlumpf M, et al. Effect of experimental cerebral infarction in rat brain on catecholamines and behavior. Nature. 1975;255:332–4. 5. Robinson RG, Kubos KL, Starr LB, et al. Mood changes in stroke patients: relationship to lesion location. Compr Psychiatry. 1983;24:555–66. 6. Starkstein SE, Robinson RG, Price TR. Comparison of cortical and subcortical lesions in the production of post-stroke mood disorders. Brain. 1987;110:1045–59. 7. Astrom M, Adolfsson R, Asplund K. Major depression in stroke patients. A 3-year longitudinal study. Stroke. 1993;24:976–82. 8. Bhogal SK, Teasell R, Foley N, Speechley M. Lesion location and poststroke depression: systematic review of the methodological limitations in the literature. Stroke. 2004;35:794–802. 9. Morris PL, Robinson RG, Raphael B, Hopwood MJ. Lesion location and poststroke depression. J Neuropsychiatry Clin Neurosci. 1996;8:399– 403. 10. Starkstein SE, Robinson RG, Berthier ML, et al. Depressive disorder following posterior circulation compared with middle cerebral artery infarcts. Brain. 1988;111: 375–87. 11. Robinson RG. Depression and lesion location in stroke. In Behavior and Mood Disorder in Focal Brain Lesions, ed. J. Bogousslavsky and J.L. Cummings, Cambridge: Cambridge University Press, 2000; pp. 95–121. 12. Morris PL, Robinson RG, Raphael B. Prevalence and course of depressive disorders in hospitalized stroke patients. Int J Psychiatr Med. 1990;20:349–64. 13. Robinson RG, Starr LB, Lipsey JR, et al. A two year longitudinal study of post-stroke mood disorders: in-hospital prognostic factors associated with six month outcome. J Nerv Ment Dis. 1985;173:221–26. 14. Gainotti G, Azzoni A, Gasparini F, et al. Relation of lesion location to verbal and nonverbal mood measures in stroke patients. Stroke. 1997;28:2145–9. 15. Andersen G, Vestergaard K, Ingemann-Nielsen M, Lauritzen L. Risk factors for post-stroke depression. Acta Psychiatr Scand. 1995;92:193–8. 16. House A, Dennis M, Warlow C, et al. Mood disorders after stroke and their relation to lesion location. A CT scan study. Brain. 1990;113(4):1113–29. 17. Herrmann N, Black SE, Lawrence J, et al. The Sunnybrook Stroke Study: A prospective study of depressive symptoms and functional outcome. Stroke. 1998;29:618–24. 18. Ng KC, Chan KL, Straughan PT. A study of post-stroke depression in a rehabilitative center. Acta Psychiatr Scand. 1995;92:75–9. 19. Paolucci S, Antonucci G, Pratesi L, et al. Poststroke depression and its role in rehabilitation of inpatients. Arch Phys Med Rehabil. 1995;80:985–90. 20. MacHale SM, O’Rourke SJ, Wardlaw JM, Dennis M. Depression and its relation to lesion location after stroke. J Neurol Neurosurg Psychiatry. 1998;64:371–4. 21. Shimoda K, Robinson RG. The relationship between poststroke depression and lesion location in long-term follow-up. Biol Psychiatry. 1999;45:187–192. 22. Robinson RG. The controversy over post-stroke depression and lesion location. Psychiatric Times. 2003;20:39–40. 23. Zhang Y, Zhao H, Fang Y, Wang S, Zhou H. The association between lesion location, sex and poststroke depression: Meta-analysis. Brain Behav. 2017;7(10):e00788. 24. Carson AJ, MacHale S, Allen K, et al. Depression after stroke and lesion location: a systematic review. Lancet. 2000;356:122–6. 25. Wei N, Yong W, Li X, et al. Post-stroke depression and lesion location: a systematic review. J Neurol. 2015;262: 81–90. 26. Bhogal SK, Teasell R, Foley N, Speechley M. Lesion location and poststroke depression: systematic review of the methodological limitations in the literature. Stroke. 2004;35:794–802. 27. Heller W, Etienne MA, Miller GA. Patterns of perceptual asymmetry in depression and anxiety: Implications for neuropsychological models of emotion and psychopathology // J Abnorm Psychol. 1995;104:327–33. 28. Singh A, Herrmann N, Black SE. The importance of lesion location in poststroke depression: A critical review. Can J Psychiatry. 1998;43:921–7. 29. Carota A, Paolucci S. Depression after stroke In Godefroy O., Bogousslavsky J. ed. The Behavioral and Cognitive Neurology of Stroke. Cambridge University Press. 2007. P. 548–70. 30. Manes F, Paradiso S, Robinson RG. Neuropsychiatric effects of insular stroke // J Nerv Ment Dis. 1999;187(12):707–12. 31. Grasso MG, Pantano P, Ricci M, et al. Mesial temporal cortex hypoperfusion is associated with depression in subcortical stroke. Stroke. 1994;25:980–5. 32. Goldstein K. Language and language disturbances. New York: Grune and Stratton; 1948. 33. Starkstein SE, Fedoroff JP, Price TR, et al. Catastrophic reaction after cerebrovascular lesions: frequency, correlates, and validation of a scale. J Neuropsychiatry Clin Neurosci. 1993;5:189–94. 34. Benson DF. Psychiatric effects of dysphasia. Br J Psychiatry. 1973;123:555–66. 35. Nickel A, Thomalla G. Post-Stroke Depression: Impact of Lesion Location and Methodological Limitations-A Topical Review. Front Neurol. 2017;8:498. 36. Teodorczuk A, Firbank MJ, Pantoni L, et al. Relationship between baseline white-matter changes and development of late-life depressive symptoms: 3-year results from the LADIS study. Psychol Med. 2010;40:603–10. 37. Vataja R, Pohjasvaara T, Mantyla R, et al. Depression-executive dysfunction syndrome in stroke patients. Am J Geriatr Psychiatry. 2005;13:99–107. 38. McLennan SN, Mathias JL. The depression-executive dysfunction (DED) syndrome and response to antidepressants: a meta-analytic review. Int J Geriatr Psychiatry. 2010;25:933–44. 39. Kutlubaev MA. [Neuroimmune mechanisms in the development of poststroke depression] Zh Nevrol Psikhiatr Im S S Korsakova. 2013;2:76–9. Russian. PMID: 23667915 40. Harney JH, Fulton C, Ross ED, Rush AJ. Dexamethasone suppression test and onset of poststroke depression in patients with ischemic infarction. J Clin Psychiatry. 1993;54:343–8. 41. Astrm M, Olsson T, Asplund K. Different linkage of depression to hypercortisolism early versus late after stroke. A 3-year longitudinal study. Stroke. 1993;24:52–7. 42. Dam H, Pedersen HE, Damkjaer M, Ahlgren P. Dexamethasone suppression test in depressive stroke patients. Acta Neurol Scand. 1991;84:14–7. 43. Mak KK, Kong WY, Mak A, et al. Polymorphisms of the serotonin transporter gene and post-stroke depression: a meta-analysis. J Neurol Neurosurg Psychiatry. 2013;84:322–9. 44. Kim JM, Kang HJ, Kim JW, Bae KY, Kim SW, Kim JT, Park MS, Cho KH. Associations of Tumor Necrosis Factor-. and Interleukin-1. Levels and Polymorphisms with Post-Stroke Depression. Am J Geriatr Psychiatry. 2017;25:1300–8. 45. Vakhnina NV. Depression after stroke: causes, diagnosis and treatment. Effectivnaya farmakoterapiya [Effective pharmacotherapy]. 2013;4:40–8. Russian. 46. Aben I, Denollet J, Lousberg R, et al. Personality and vulnerability to depression in stroke patients: A 1-year prospective follow-up study // Stroke. 2002;33: 2391–95. 47. Morris PL, Robinson RG, Raphael B. Prevalence and course of depressive disorders in hospitalized stroke patients. Int J Psychiatry Med. 1990;20:349–64. 48. Aben I, Verhey F, Strick J, et al. A comparative study into the one year cumulative incidence of depression after stroke and myocardial infarction. J Neurol Neurosurg Psychiatry. 2003;74:581–5. 49. Ouimet MA, Primeau F, Cole MG. Psychosocial risk factors in poststroke depression: A systematic review. Can J Psychiatry. 2001;46:819–28. 50. Hollocks MJ, Lawrence AJ, Brookes RL, et al. Differential relationships between apathy and depression with white matter microstructural changes and functional outcomes. Brain. 2015;138(12): 803–15. 51. Kutlubaev MA, Duncan F, Mead GE. Biological correlates of poststroke fatigue: a systematic review. Acta Neurologica Scandinavica 2012;125:219–27. 52. Kutlubaev MA, Mendelevich VD, Akhmadeeva LR. [Poststroke neuropsychiatric affective disorders]. Psikhicheskoe zdorov’e [Psychological health]. 2016;9:65–73. Russian.
DOI: http://dx.doi.org/10.24411/1560-957X-2018-1%25x
Метрики статей
Metrics powered by PLOS ALM